Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-26T22:39:40.228Z Has data issue: false hasContentIssue false
  • English
  • Français

How much do we know about schizophrenia and how well do we know it? Evidence from the Schizophrenia Library

Published online by Cambridge University Press:  20 February 2014

S. L. Matheson ,
A. M. Shepherd  and
V. J. Carr
S. L. Matheson*
Affiliation:
Schizophrenia Research Institute, Darlinghurst, Sydney, NSW, Australia Research Unit for Schizophrenia Epidemiology, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
A. M. Shepherd
Affiliation:
Schizophrenia Research Institute, Darlinghurst, Sydney, NSW, Australia Research Unit for Schizophrenia Epidemiology, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
V. J. Carr
Affiliation:
Schizophrenia Research Institute, Darlinghurst, Sydney, NSW, Australia Research Unit for Schizophrenia Epidemiology, School of Psychiatry, University of New South Wales, Sydney, NSW, Australia
*
* Address for correspondence: S. L. Matheson, M.P.H., UNSW Research Unit for Schizophrenia Epidemiology, O'Brien Centre, Level 4, St Vincent's Hospital, 394–404 Victoria Street, Darlinghurst, NSW 2010, Australia. (Email: [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Background.

True findings about schizophrenia remain elusive; many findings are not replicated and conflicting results are common. Well-conducted systematic reviews have the ability to make robust, generalizable conclusions, with good meta-analyses potentially providing the closest estimate of the true effect size. In this paper, we undertake a systematic approach to synthesising the available evidence from well-conducted systematic reviews on schizophrenia.

Method.

Reviews were identified by searching Medline, EMBASE, CINAHL, Current Contents and PsycINFO. The decision to include or exclude reviews, data extraction and quality assessments were conducted in duplicate. Evidence was graded as high quality if reviews contained large samples and robust results; and as moderate quality if reviews contained imprecision, inconsistency, smaller samples or study designs that may be prone to bias.

Results.

High- and moderate-quality evidence shows that numerous psychosocial and biomedical treatments are effective. Patients have relatively poor cognitive functioning, and subtle, but diverse, structural brain alterations, altered electrophysiological functioning and sleep patterns, minor physical anomalies, neurological soft signs, and sensory alterations. There are markers of infection, inflammation or altered immunological parameters; and there is increased mortality from a range of causes. Risk for schizophrenia is increased with cannabis use, pregnancy and birth complications, prenatal exposure to Toxoplasma gondii, childhood central nervous system viral infections, childhood adversities, urbanicity and immigration (first and second generation), particularly in certain ethnic groups. Developmental motor delays and lower intelligence quotient in childhood and adolescence are apparent.

Conclusions.

We conclude that while our knowledge of schizophrenia is very substantial, our understanding of it remains limited.

Keywords

Biological aetiologyclinical phenomenologycognitionepidemiologyintervention efficacyrisk factors
Type
Review Articles
Information
Psychological Medicine , Volume 44 , Issue 16 , December 2014 , pp. 3387 - 3405
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Achim, AM, Lepage, M (2005). Episodic memory-related activation in schizophrenia: meta-analysis. British Journal of Psychiatry 187, 500–509.CrossRefGoogle ScholarPubMed
Achim, AM, Maziade, M, Raymond, E, Olivier, D, Merette, C, Roy, M (2011). How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophrenia Bulletin 37, 811–821.CrossRefGoogle ScholarPubMed
Adams, CE, Awad, G, Rathbone, J, Thornley, B (2007). Chlorpromazine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD000284. doi:10.1002/14651858.CD000284.pub2.CrossRefGoogle ScholarPubMed
Adriano, F, Caltagirone, C, Spalletta, G (2012). Hippocampal volume reduction in first-episode and chronic schizophrenia: a review and meta-analysis. Neuroscientist 18, 180–200.CrossRefGoogle ScholarPubMed
Adriano, F, Spoletini, I, Caltagirone, C, Spalletta, G (2010). Updated meta-analyses reveal thalamus volume reduction in patients with first-episode and chronic schizophrenia. Schizophrenia Research 123, 1–4.CrossRefGoogle ScholarPubMed
Aleman, A, Agrawal, N, Morgan, KD, David, AS (2006). Insight in psychosis and neuropsychological function: meta-analysis. British Journal of Psychiatry 189, 204–212.CrossRefGoogle ScholarPubMed
Aleman, A, Sommer, IE, Kahn, RS (2007). Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. Journal of Clinical Psychiatry 68, 416–421.CrossRefGoogle ScholarPubMed
Allen, NC, Bagade, S, McQueen, MB, Ioannidis, JPA, Kavvoura, FK, Khoury, MJ, Tanzi, RE, Bertram, L (2008). Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nature Genetics 40, 827–834.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Parker, AG, Hetrick, SE, McGorry, PD, Gleeson, JF (2011). Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis. Schizophrenia Bulletin 37, 619–630.CrossRefGoogle ScholarPubMed
Alvarez-Jimenez, M, Priede, A, Hetrick, SE, Bendall, S, Killackey, E, Parker, AG, McGorry, PD, Gleeson, JF (2012). Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophrenia Research 139, 116–128.CrossRefGoogle ScholarPubMed
Anderson, KK, Fuhrer, R, Malla, AK (2010). The pathways to mental health care of first-episode psychosis patients: a systematic review. Psychological Medicine 40, 1585–1597.CrossRefGoogle ScholarPubMed
Anticevic, A, Van Snellenberg, JX, Cohen, RE, Repovs, G, Dowd, EC, Barch, DM (2012). Amygdala recruitment in schizophrenia in response to aversive emotional material: a meta-analysis of neuroimaging studies. Schizophrenia Bulletin 38, 608–621.CrossRefGoogle ScholarPubMed
Arias, I, Sorlozano, A, Villegas, E, de Dios Luna, J, McKenney, K, Cervilla, J, Gutierrez, B, Gutierrez, J (2011). Infectious agents associated with schizophrenia: a meta-analysis. Schizophrenia Research 136, 128–136.CrossRefGoogle ScholarPubMed
Arnone, D, McIntosh, AM, Tan, GM, Ebmeier, KP, Tan, GMY (2008). Meta-analysis of magnetic resonance imaging studies of the corpus callosum in schizophrenia. Schizophrenia Research 101, 124–132.CrossRefGoogle ScholarPubMed
Baiano, M, David, A, Versace, A, Churchill, R, Balestrieri, M, Brambilla, P (2007). Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophrenia Research 93, 1–12.CrossRefGoogle Scholar
Beauchamp, G, Gagnon, A (2004). Influence of diagnostic classification on gender ratio in schizophrenia – a meta-analysis of youths hospitalized for psychosis. Social Psychiatry and Psychiatric Epidemiology 39, 1017–1022.CrossRefGoogle ScholarPubMed
Begemann, MJH, Dekker, CF, van Lunenburg, M, Sommer, IE (2012). Estrogen augmentation in schizophrenia: a quantitative review of current evidence. Schizophrenia Research 141, 179–184.CrossRefGoogle ScholarPubMed
Belgamwar, RB, El-Sayeh, HGG (2011). Aripiprazole versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, Issue 8. Art. No.: CD006622. doi:10.1002/14651858.CD006622.pub2.CrossRefGoogle ScholarPubMed
Berger, GE, Wood, SJ, Pantelis, C, Velakoulis, D, Wellard, RM, McGorry, PD (2002). Implications of lipid biology for the pathogenesis of schizophrenia. Australian and New Zealand Journal of Psychiatry 36, 355–366.CrossRefGoogle ScholarPubMed
Bird, V, Premkumar, P, Kendall, T, Whittington, C, Mitchell, J, Kuipers, E (2010). Early intervention services, cognitive-behavioural therapy and family intervention in early psychosis: systematic review. British Journal of Psychiatry 197, 350–356.CrossRefGoogle ScholarPubMed
Bokat, CE, Goldberg, TE (2003). Letter and category fluency in schizophrenic patients: a meta-analysis. Schizophrenia Research 64, 73–78.CrossRefGoogle ScholarPubMed
Boonstra, N, Klaassen, R, Sytema, S, Marshall, M, De Haan, L, Wunderink, L, Wiersma, D (2012). Duration of untreated psychosis and negative symptoms – a systematic review and meta-analysis of individual patient data. Schizophrenia Research 142, 12–19.CrossRefGoogle ScholarPubMed
Bora, E, Fornito, A, Radua, J, Walterfang, M, Seal, M, Wood, SJ, Yücel, M, Velakoulis, D, Pantelis, C (2011). Neuroanatomical abnormalities in schizophrenia: a multimodal voxelwise meta-analysis and meta-regression analysis. Schizophrenia Research 127, 46–57.CrossRefGoogle ScholarPubMed
Bora, E, Pantelis, C (2013). Theory of mind impairments in first-episode psychosis, individuals at ultra-high risk for psychosis and in first-degree relatives of schizophrenia: systematic review and meta-analysis. Schizophrenia Research 144, 31–36.CrossRefGoogle ScholarPubMed
Bora, E, Yucel, M, Pantelis, C (2009 a). Theory of mind impairment in schizophrenia: meta-analysis. Schizophrenia Research 109, 1–9.CrossRefGoogle ScholarPubMed
Bora, E, Yucel, M, Pantelis, C (2009 b). Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. British Journal of Psychiatry 195, 475–482.CrossRefGoogle ScholarPubMed
Borenstein, M, Hedges, LV, Higgins, JPT, Rothstein, HR (2009). Introduction to Meta-Analysis. John Wiley and Sons: Chichester.CrossRefGoogle Scholar
Bourque, F, van der Ven, E, Malla, A (2011). A meta-analysis of the risk for psychotic disorders among first- and second-generation immigrants. Psychological Medicine 41, 897–910.CrossRefGoogle ScholarPubMed
Bradley, AJ, Dinan, TG (2010). A systematic review of hypothalamic–pituitary–adrenal axis function in schizophrenia: implications for mortality. Journal of Psychopharmacology 24, 91–118.CrossRefGoogle ScholarPubMed
Bramon, E, McDonald, C, Croft, RJ, Landau, S, Filbey, F, Gruzelier, JH, Sham, PC, Frangou, S, Murray, RM (2005). Is the P300 wave an endophenotype for schizophrenia? A meta-analysis and a family study. Neuroimage 27, 960–968.CrossRefGoogle Scholar
Bramon, E, Rabe-Hesketh, S, Sham, P, Murray, RM, Frangou, S (2004). Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophrenia Research 70, 315–329.CrossRefGoogle ScholarPubMed
Brugger, S, Davis, JM, Leucht, S, Stone, JM (2011). Proton magnetic resonance spectroscopy and illness stage in schizophreniaa systematic review and meta-analysis. Biological Psychiatry 69, 495–503.CrossRefGoogle ScholarPubMed
Button, KS, Ioannidis, JPA, Mokrysz, C, Nosek, BA, Flint, J, Robinson, ESJ, Munafò, MR (2013). Power failure: why small sample size undermines the reliability of neuroscience. Nature Reviews Neuroscience 14, 365–378.CrossRefGoogle ScholarPubMed
Calkins, ME, Iacono, WG, Ones, DS (2008). Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain and Cognition 68, 436–461.CrossRefGoogle ScholarPubMed
Cannon, M, Jones, PB, Murray, RM (2002). Obstetric complications and schizophrenia: historical and meta-analytic review. American Journal of Psychiatry 159, 1080–1092.CrossRefGoogle ScholarPubMed
Cantor-Graae, E, Selten, JP (2005). Schizophrenia and migration: a meta-analysis and review. American Journal of Psychiatry 162, 12–24.CrossRefGoogle ScholarPubMed
Catts, VS, Catts, SV, O'Toole, BI, Frost, AD, Frost, ADJ (2008). Cancer incidence in patients with schizophrenia and their first-degree relatives – a meta-analysis. Acta Psychiatrica Scandinavica 117, 323–336.CrossRefGoogle ScholarPubMed
Chakos, M, Lieberman, J, Hoffman, E, Bradford, D, Sheitman, B (2001). Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. American Journal of Psychiatry 158, 518–526.Google ScholarPubMed
Chan, RCK, Di, X, McAlonan, GM, Gong, QY (2011). Brain anatomical abnormalities in high-risk individuals, first-episode, and chronic schizophrenia: an activation likelihood estimation meta-analysis of illness progression. Schizophrenia Bulletin 37, 177–188.CrossRefGoogle ScholarPubMed
Chan, RCK, Li, H, Cheung, EFC, Gong, Q-Y (2010 a). Impaired facial emotion perception in schizophrenia: a meta-analysis. Psychiatry Research 178, 381–390.CrossRefGoogle ScholarPubMed
Chan, RCK, Xu, T, Heinrichs, RW, Yu, Y, Gong, QY (2010 b). Neurological soft signs in non-psychotic first-degree relatives of patients with schizophrenia: a systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews 34, 889–896.CrossRefGoogle ScholarPubMed
Chan, RCK, Xu, T, Heinrichs, RW, Yu, Y, Wang, Y (2010 c). Neurological soft signs in schizophrenia: a meta-analysis. Schizophrenia Bulletin 36, 1089–1104.CrossRefGoogle ScholarPubMed
Chong, TW, Castle, DJ (2004). Layer upon layer: thermoregulation in schizophrenia. Schizophrenia Research 69, 149–157.CrossRefGoogle ScholarPubMed
Chouinard, S, Poulin, J, Stip, E, Godbout, R (2004). Sleep in untreated patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 30, 957–967.CrossRefGoogle ScholarPubMed
Chuma, J, Mahadun, P (2011). Predicting the development of schizophrenia in high-risk populations: systematic review of the predictive validity of prodromal criteria. British Journal of Psychiatry 199, 361–366.CrossRefGoogle ScholarPubMed
Cochrane Collaboration (2008). Cochrane Handbook for Systematic Reviews of Interventions. John Wiley and Sons: Chichester.Google Scholar
Cohen, AS, Brown, LA, Auster, TL (2012). Olfaction, “olfiction,” and the schizophrenia-spectrum: an updated meta-analysis on identification and acuity. Schizophrenia Research 135, 152–157.CrossRefGoogle ScholarPubMed
Cohen, AS, Minor, KS (2010). Emotional experience in patients with schizophrenia revisited: meta-analysis of laboratory studies. Schizophrenia Bulletin 36, 143–150.CrossRefGoogle ScholarPubMed
Cohen, J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn. Erlbaum: Hillsdale, NJ.Google Scholar
Copeland, LA, Zeber, JE, Pugh, MJ, Mortensen, EM, Restrepo, MI, Lawrence, VA (2008). Postoperative complications in the seriously mentally ill: a systematic review of the literature. Annals of Surgery 248, 31–38.CrossRefGoogle ScholarPubMed
Crossley, NA, Constante, M, McGuire, P, Power, P (2010). Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis. British Journal of Psychiatry 196, 434–439.CrossRefGoogle ScholarPubMed
Crowther, R, Marshall, M, Bond, G, Huxley, P (2001). Vocational rehabilitation for people with severe mental illness. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD003080. doi:10.1002/14651858.CD003080.CrossRefGoogle ScholarPubMed
de Gracia Dominguez, M, Viechtbauer, W, Simons, CJ, van Os, J, Krabbendam, L (2009). Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychological Bulletin 135, 157–171.CrossRefGoogle Scholar
de Leon, J, Diaz, FJ (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research 76, 135–157.CrossRefGoogle ScholarPubMed
de Wilde, OM, Bour, LJ, Dingemans, PM, Koelman, JH, Linszen, DH, Koelman, JHTM (2007). A meta-analysis of P50 studies in patients with schizophrenia and relatives: differences in methodology between research groups. Schizophrenia Research 97, 137–151.CrossRefGoogle ScholarPubMed
Demeulemeester, M, Amad, A, Bubrovszky, M, Pins, D, Thomas, P, Jardri, R (2012). What is the real effect of 1-Hz repetitive transcranial magnetic stimulation on hallucinations? Controlling for publication bias in neuromodulation trials. Biological Psychiatry 71, e15–e16.CrossRefGoogle ScholarPubMed
Dibben, CR, Rice, C, Laws, K, McKenna, PJ (2009). Is executive impairment associated with schizophrenic syndromes? A meta-analysis. Psychological Medicine 39, 381–392.CrossRefGoogle ScholarPubMed
Dickinson, D, Ramsey, ME, Gold, JM (2007). Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry 64, 532–542.CrossRefGoogle ScholarPubMed
Dickson, H, Laurens, KR, Cullen, AE, Hodgins, S (2012). Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia. Psychological Medicine 42, 743–755.CrossRefGoogle ScholarPubMed
Dieterich, M, Irving, CB, Park, B, Marshall, M (2010). Intensive case management for severe mental illness. Cochrane Database of Systematic Reviews, Issue 10. Art. No.: CD007906. doi:10.1002/14651858.CD007906.pub2.Google ScholarPubMed
Dlabac-de Lange, JJ, Knegtering, R, Aleman, A (2010). Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. Journal of Clinical Psychiatry 71, 411–418.CrossRefGoogle ScholarPubMed
Duggan, L, Fenton, M, Rathbone, J, Dardennes, R, El-Dosoky, A, Indran, S (2005). Olanzapine for schizophrenia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001359. doi:10.1002/14651858.CD001359.pub2.CrossRefGoogle ScholarPubMed
Eack, SM, Newhill, CE (2007). Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophrenia Bulletin 33, 1225–1237.CrossRefGoogle ScholarPubMed
Ellison-Wright, I, Bullmore, E (2009). Meta-analysis of diffusion tensor imaging studies in schizophrenia. Schizophrenia Research 108, 3–10.CrossRefGoogle ScholarPubMed
Esterberg, M, Trotmana, HD, Holtzmana, C, Compton, MT, Walker, EF (2010). The impact of a family history of psychosis on age-at-onset and positive and negative symptoms of schizophrenia: a meta-analysis. Schizophrenia Research 120, 121–130.CrossRefGoogle ScholarPubMed
Farooq, S, Large, M, Nielssen, O, Waheed, W (2009). The relationship between the duration of untreated psychosis and outcome in low- and-middle income countries: a systematic review and meta analysis. Schizophrenia Research 109, 15–23.CrossRefGoogle ScholarPubMed
Fazel, S, Gulati, G, Linsell, L, Geddes, JR, Grann, M (2009). Schizophrenia and violence: systematic review and meta-analysis. PLoS Medicine 6, 120.CrossRefGoogle ScholarPubMed
Fazel, S, Khosla, V, Doll, H, Geddes, J (2008). The prevalence of mental disorders among the homeless in western countries: systematic review and meta-regression analysis. PLoS Medicine 5, e225.CrossRefGoogle ScholarPubMed
Fazel, S, Seewald, K (2012). Severe mental illness in 33 588 prisoners worldwide: systematic review and meta-regression analysis. British Journal of Psychiatry 200, 364–373.CrossRefGoogle ScholarPubMed
Fekadu, A, Shibre, T, Cleare, AJ (2010). Toxoplasmosis as a cause for behaviour disorders – overview of evidence and mechanisms. Folia Parasitologica 57, 105–113.CrossRefGoogle ScholarPubMed
Fenton, WS, Hibbeln, J, Knable, M (2000). Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biological Psychiatry 47, 8–21.CrossRefGoogle ScholarPubMed
Fett, AK, Viechtbauer, W, Dominguez, MD, Penn, DL, van Os, J, Krabbendam, L (2011). The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: a meta-analysis. Neuroscience and Biobehavioral Reviews 35, 573–588.CrossRefGoogle ScholarPubMed
Folsom, D, Jeste, DV (2002). Schizophrenia in homeless persons: a systematic review of the literature. Acta Psychiatrica Scandinavica 105, 404–413.CrossRefGoogle ScholarPubMed
Forbes, NF, Carrick, LA, McIntosh, AM, Lawrie, SM (2009). Working memory in schizophrenia: a meta-analysis. Psychological Medicine 39, 889–905.CrossRefGoogle ScholarPubMed
Fusar-Poli, P, Bonoldi, I, Yung, AR, Borgwardt, S, Kempton, MJ, Valmaggia, L, Barale, F, Caverzasi, E, McGuire, P (2012 a). Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry 69, 220–229.CrossRefGoogle ScholarPubMed
Fusar-Poli, P, Deste, G, Smieskova, R, Barlati, S, Yung, AR, Howes, O, Stieglitz, RD, Vita, A, McGuire, P, Borgwardt, S (2012 b). Cognitive functioning in prodromal psychosis: a meta-analysis. Archives of General Psychiatry 69, 562–571.CrossRefGoogle ScholarPubMed
Fusar-Poli, P, Meyer-Lindenberg, A (2013 a). Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F/11C]-DOPA PET studies. Schizophrenia Bulletin 39, 33–42.CrossRefGoogle ScholarPubMed
Fusar-Poli, P, Meyer-Lindenberg, A (2013 b). Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density. Schizophrenia Bulletin 39, 22–32.CrossRefGoogle ScholarPubMed
Fusar-Poli, P, Smieskova, R, Kempton, MJ, Ho, BC, Andreasen, NC, Borgwardt, S (2013). Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neuroscience and Biobehavioral Reviews 37, 1680–1691.CrossRefGoogle ScholarPubMed
Galderisi, S, Mucci, A, Volpe, U, Boutros, N (2009). Evidence-based medicine and electrophysiology in schizophrenia. Clinical EEG and Neuroscience 40, 62–77.CrossRefGoogle ScholarPubMed
Goghari, VM (2011). Executive functioning-related brain abnormalities associated with the genetic liability for schizophrenia: an activation likelihood estimation meta-analysis. Psychological Medicine 41, 1239–1252.CrossRefGoogle ScholarPubMed
Gold, C, Solli, HP, Kruger, V, Lie, SA (2009). Dose–response relationship in music therapy for people with serious mental disorders: systematic review and meta-analysis. Clinical Psychology Review 29, 193–207.CrossRefGoogle ScholarPubMed
Golembo-Smith, S, Walder, DJ, Daly, MP, Mittal, VA, Kline, E, Reeves, G, Schiffman, J (2012). The presentation of dermatoglyphic abnormalities in schizophrenia: a meta-analytic review. Schizophrenia Research 142, 1–11.CrossRefGoogle ScholarPubMed
GRADE Working Group (2004). Grading quality of evidence and strength of recommendations. BMJ (Clinical Research Edition) 328, 1490.CrossRefGoogle Scholar
Green, MJ, Matheson, SL, Shepherd, A, Weickert, CS, Carr, VJ (2011). Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Molecular Psychiatry 16, 960–972.CrossRefGoogle ScholarPubMed
Guyatt, G, Oxman, AD, Akl, EA, Kunz, R, Vist, G, Brozek, J, Norris, S, Falck-Ytter, Y, Glasziou, P, deBeer, H, Jaeschke, R, Rind, D, Meerpohl, J, Dahm, P, Schünemann, HJ (2011 a). GRADE guidelines: 1. Introduction – GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 64, 383–394.CrossRefGoogle ScholarPubMed
Guyatt, GH, Oxman, AD, Kunz, R, Woodcock, J, Brozek, J, Helfand, M, Alonso-Coello, P, Glasziou, O, Jaeschke, R, Akl, EA, Norris, S, Vist, G, Dahm, P, Shukla, VK, Higgins, J, Falck-Ytter, Y, Schünemann, HJ; GRADE Working Group (2011 b). GRADE guidelines: 7. Rating the quality of evidence – inconsistency. Journal of Clinical Epidemiology 64, 1294–1302.CrossRefGoogle ScholarPubMed
Guyatt, GH, Oxman, AD, Kunz, R, Brozek, J, Alonso-Coello, P, Rind, D, Devereaux, PJ, Montori, VM, Freyschuss, B, Vist, G, Jaeschke, R, Williams, JWJ, Murad, MH, Sinclair, D, Falck-Ytter, Y, Meerpohl, J, Whittington, C, Thorlund, K, Andrews, J, Schünemann, HJ (2011 c). GRADE guidelines: 6. Rating the quality of evidence – imprecision. Journal of Clinical Epidemiology 64, 1283–1293.CrossRefGoogle ScholarPubMed
Guyatt, GH, Oxman, AD, Kunz, R, Woodcock, J, Brozek, J, Helfand, M, Alonso-Coello, P, Falck-Ytter, Y, Jaeschke, R, Vist, G, Akl, EA, Post, PN, Norris, S, Meerpohl, J, Shukla, VK, Nasser, M, Schünemann, HJ; GRADE Working Group (2011 d). GRADE guidelines: 8. Rating the quality of evidence – indirectness. Journal of Clinical Epidemiology 64, 1303–1310.CrossRefGoogle ScholarPubMed
Haijma, SV, Van Haren, N, Cahn, W, Koolschijn, PCMP, Hulshoff Pol, HE, Kahn, RS (2013). Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophrenia Bulletin 39, 1129–1138.CrossRefGoogle ScholarPubMed
Harrison, PJ, Freemantle, N, Geddes, JR (2003). Meta-analysis of brain weight in schizophrenia. Schizophrenia Research 64, 25–34.CrossRefGoogle ScholarPubMed
Howes, O, Kambeitz, J, Kim, E, Stahl, D, Slifstein, M, Abi-Dargham, A, Kapur, S (2012). The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Archives of General Psychiatry 69, 776–786.CrossRefGoogle Scholar
Ioannidis, JPA (2005). Why most published research findings are false. PLoS Medicine 2, e124.CrossRefGoogle ScholarPubMed
Irani, F, Seligman, S, Kamath, V, Kohler, C, Gur, RC (2012). A meta-analysis of emotion perception and functional outcomes in schizophrenia. Schizophrenia Research 137, 203–211.CrossRefGoogle ScholarPubMed
Irving, CB, Adams, CE, Lawrie, SM (2006). Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD003082. doi:10.1002/14651858.CD003082.pub2.CrossRefGoogle Scholar
Jardri, R, Pouchet, A, Pins, D, Thomas, P (2011). Cortical activations during auditory verbal hallucinations in schizophrenia: a coordinate-based meta-analysis. American Journal of Psychiatry 168, 73–81.CrossRefGoogle ScholarPubMed
Johnson-Selfridge, M, Zalewski, C (2001). Moderator variables of executive functioning in schizophrenia: meta-analytic findings. Schizophrenia Bulletin 27, 305–316.CrossRefGoogle ScholarPubMed
Jones, C, Hacker, D, Cormac, I, Meaden, A, Irving, CB (2012). Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD008712. doi:10.1002/14651858.CD008712.pub2.CrossRefGoogle ScholarPubMed
Kempton, M, Stahl, D, Williams, SCR, DeLisi, LE (2010). Progressive lateral ventricular enlargement in schizophrenia: a meta-analysis of longitudinal MRI studies. Schizophrenia Research 120, 54–62.CrossRefGoogle ScholarPubMed
Keshavan, MS, Tandon, R, Boutros, NN, Nasrallah, HA (2008). Schizophrenia, part 3 – Just the Facts. What we know in 2008: neurobiology. Schizophrenia Research 106, 89–107.CrossRefGoogle ScholarPubMed
Khandaker, GM, Barnett, JH, White, IR, Jones, PB (2011). A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia. Schizophrenia Research 132, 220–227.CrossRefGoogle ScholarPubMed
Khandaker, GM, Zimbron, J, Dalman, C, Lewis, G, Jones, PB (2012). Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophrenia Research 139, 161–168.CrossRefGoogle ScholarPubMed
Khandaker, GM, Zimbron, J, Lewis, G, Jones, PB (2013). Prenatal maternal infection, neurodevelopment and adult schizophrenia: a systematic review of population based studies. Psychological Medicine 43, 239–257.CrossRefGoogle ScholarPubMed
Kinney, DK, Teixeira, P, Hsu, D, Napoleon, SC, Crowley, DJ, Miller, A, Hyman, W, Huang, E (2009). Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin D deficiency and infections? Schizophrenia Bulletin 35, 582–595.CrossRefGoogle ScholarPubMed
Kirkbride, JB, Errazuriz, A, Croudace, TJ, Morgan, C, Jackson, D, Boydell, J, Murray, RM, Jones, PB (2012). Incidence of schizophrenia and other psychoses in England, 1950–2009: a systematic review and meta-analyses. PLOS ONE 7, e31660.CrossRefGoogle ScholarPubMed
Knowles, EEM, David, AS, Reichenberg, A (2010). Processing speed deficits in schizophrenia: reexamining the evidence. American Journal of Psychiatry 167, 828–835.CrossRefGoogle ScholarPubMed
Kohler, C, Walker, J, Martin, E, Healey, K, Moberg, P (2010). Facial emotion perception in schizophrenia: a meta-analytic review. Schizophrenia Bulletin 36, 1009–1019.CrossRefGoogle ScholarPubMed
Kompus, K, Westerhausen, R, Hugdahl, K (2011). The “paradoxical” engagement of the primary auditory cortex in patients with auditory verbal hallucinations: a meta-analysis of functional neuroimaging studies. Neuropsychologia 49, 3361–3369.CrossRefGoogle Scholar
Koskinen, J, Lohonen, J, Koponen, H, Isohanni, M, Miettunen, J (2010). Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophrenia Bulletin 36, 1115–1130.CrossRefGoogle ScholarPubMed
Krabbendam, L, Arts, B, van Os, J, Aleman, A (2005). Cognitive functioning in patients with schizophrenia and bipolar disorder: a quantitative review. Schizophrenia Research 80, 137–149.CrossRefGoogle ScholarPubMed
Kraguljac, NV, Reid, M, White, D, Jones, R, den Hollander, J, Lowman, D, Lahti, AC (2012). Neurometabolites in schizophrenia and bipolar disorder – a systematic review and meta-analysis. Psychiatry Research 203, 111–125.CrossRefGoogle ScholarPubMed
Kuhn, S, Gallinat, J (2012). Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia. Schizophrenia Bulletin 38, 779–786.CrossRefGoogle ScholarPubMed
Kurtz, MM, Mueser, KT (2008). A meta-analysis of controlled research on social skills training for schizophrenia. Journal of Consulting and Clinical Psychology 76, 491–504.CrossRefGoogle ScholarPubMed
Kurtz, MM, Richardson, CL (2012). Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research. Schizophrenia Bulletin 38, 1092–1104.CrossRefGoogle ScholarPubMed
Kuswanto, CN, Teh, I, Lee, TS, Sim, K (2012). Diffusion tensor imaging findings of white matter changes in first episode schizophrenia: a systematic review. Clinical Psychopharmacology and Neuroscience 10, 13–24.CrossRefGoogle ScholarPubMed
Large, M, Nielssen, O (2008). Evidence for a relationship between the duration of untreated psychosis and the proportion of psychotic homicides prior to treatment. Social Psychiatry and Psychiatric Epidemiology 43, 37–44.Google ScholarPubMed
Large, M, Sharma, S, Compton, MT, Slade, T, Nielssen, O (2011 a). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry 68, 555–561.CrossRefGoogle ScholarPubMed
Large, M, Smith, G, Sharma, S, Nielssen, O, Singh, SP (2011 b). Systematic review and meta-analysis of the clinical factors associated with the suicide of psychiatric in-patients. Acta Psychiatrica Scandinavica 124, 18–19.CrossRefGoogle ScholarPubMed
Large, MM, Nielssen, O, Ryan, CJ, Hayes, R (2008). Mental health laws that require dangerousness for involuntary admission may delay the initial treatment of schizophrenia. Social Psychiatry and Psychiatric Epidemiology 43, 251–256.CrossRefGoogle ScholarPubMed
Leucht, S, Kissling, W, McGrath, J (2007 a). Lithium for schizophrenia. Cochrane Database of Systematic Reviews, Issue 3. Art. No.: CD003834. doi:10.1002/14651858.CD003834.CrossRefGoogle ScholarPubMed
Leucht, S, Burkard, T, Henderson, J, Maj, M, Sartorius, N (2007 b). Physical illness and schizophrenia: a review of the literature. Acta Psychiatrica Scandinavica 116, 317–333.CrossRefGoogle ScholarPubMed
Leucht, S, Lasser, R (2006). The concepts of remission and recovery in schizophrenia. Pharmacopsychiatry 39, 161–170.CrossRefGoogle ScholarPubMed
Leucht, S, Tardy, M, Komossa, K, Heres, S, Kissling, W, Davis, JM (2012 a). Maintenance treatment with antipsychotic drugs for schizophrenia. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD008016. doi:10.1002/14651858.CD008016.pub2.CrossRefGoogle ScholarPubMed
Leucht, S, Tardy, M, Komossa, K, Heres, S, Kissling, W, Salanti, G, Davis, JM (2012 b). Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet 379, 2063–2071.CrossRefGoogle ScholarPubMed
Li, H, Chan, R, McAlonan, G, Gong, Q (2010). Facial emotion processing in schizophrenia: a meta-analysis of functional neuroimaging data. Schizophrenia Bulletin 36, 1029–1039.CrossRefGoogle ScholarPubMed
Livingston, JD, Boyd, JE (2010). Correlates and consequences of internalized stigma for people living with mental illness: a systematic review and meta-analysis. Social Science and Medicine 71, 2150–2161.CrossRefGoogle ScholarPubMed
Llerena, K, Strauss, GP, Cohen, AS (2012). Looking at the other side of the coin: a meta-analysis of self-reported emotional arousal in people with schizophrenia. Schizophrenia Research 142, 65–70.CrossRefGoogle Scholar
MacDonald, AW, Schulz, SC (2009). What we know: findings that every theory of schizophrenia should explain. Schizophrenia Bulletin 35, 493–508.CrossRefGoogle ScholarPubMed
MacDonald, AW 3rd, Thermenos, HW, Barch, DM, Seidman, LJ (2009). Imaging genetic liability to schizophrenia: systematic review of FMRI studies of patients’ nonpsychotic relatives. Schizophrenia Bulletin 35, 1142–1162.CrossRefGoogle ScholarPubMed
Maniglio, R (2009). Severe mental illness and criminal victimization: a systematic review. Acta Psychiatrica Scandinavica 119, 180–191.CrossRefGoogle ScholarPubMed
Marshall, M, Lewis, S, Lockwood, A, Drake, R, Jones, P, Croudace, T (2005). Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of General Psychiatry 62, 975–983.CrossRefGoogle ScholarPubMed
Marsman, A, Van Den Heuvel, MP, Klomp, DWJ, Kahn, RS, Luijten, PR, Hulshoff Pol, HE (2013). Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophrenia Bulletin 39, 120–129.CrossRefGoogle Scholar
Matheson, SL, Shepherd, AM, Pinchbeck, RM, Laurens, KR, Carr, VJ (2012). Childhood adversity in schizophrenia: a systematic meta-analysis. Psychological Medicine 43, 225–238.CrossRefGoogle ScholarPubMed
McGrath, J, Saha, S, Welham, J, El Saadi, O, MacCauley, C, Chant, D (2004). A systematic review of the incidence of schizophrenia: the distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Medicine 2, 13.CrossRefGoogle ScholarPubMed
McGurk, SR, Twamley, EW, Sitzer, DI, McHugo, GJ, Mueser, KT (2007). A meta-analysis of cognitive remediation in schizophrenia. American Journal of Psychiatry 164, 1791–1802.CrossRefGoogle ScholarPubMed
Menezes, NM, Arenovich, T, Zipursky, RB (2006). A systematic review of longitudinal outcome studies of first-episode psychosis. Psychological Medicine 36, 1349–1362.CrossRefGoogle ScholarPubMed
Mesholam-Gately, RI, Giuliano, AJ, Goff, KP, Faraone, SV, Seidman, LJ (2009). Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 23, 315–336.CrossRefGoogle ScholarPubMed
Meyer, JM, Stahl, SM (2009). The metabolic syndrome and schizophrenia. Acta Psychiatrica Scandinavica 119, 4–14.CrossRefGoogle ScholarPubMed
Miller, B, Messias, E, Miettunen, J, Alaraisanen, A, Jarvelin, MR, Koponen, H, Rasanen, P, Isohanni, M, Kirkpatrick, B (2011). Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophrenia Bulletin 37, 1039–1047.CrossRefGoogle ScholarPubMed
Miller, BJ, Buckley, P, Seabolt, W, Mellor, A, Kirkpatrick, B (2011). Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biological Psychiatry 70, 663–671.CrossRefGoogle ScholarPubMed
Mintz, AR, Dobson, KS, Romney, DM (2003). Insight in schizophrenia: a meta-analysis. Schizophrenia Research 61, 75–88.CrossRefGoogle ScholarPubMed
Minzenberg, MJ, Laird, AR, Thelen, S, Carter, CS, Glahn, DC (2009). Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Archives of General Psychiatry 66, 811–822.CrossRefGoogle ScholarPubMed
Moher, D, Liberati, A, Tetzlaff, J, Altman, DG; PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ (Clinical Research Ed) 151, 264–269.Google ScholarPubMed
Molloy, C, Conroy, RM, Cotter, DR, Cannon, M (2011). Is traumatic brain injury a risk factor for schizophrenia? A meta-analysis of case-controlled population-based studies. Schizophrenia Bulletin 37, 1104–1110.CrossRefGoogle ScholarPubMed
Moncrieff, J (2003). Clozapine v. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination. British Journal of Psychiatry 183, 161–166.CrossRefGoogle ScholarPubMed
Moore, TH, Zammit, S, Lingford-Hughes, A, Barnes, TR, Jones, PB, Burke, M, Lewis, G (2007). Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 370, 319–328.CrossRefGoogle ScholarPubMed
Mössler, K, Chen, X, Heldal, TO, Gold, C (2011). Music therapy for people with schizophrenia and schizophrenia-like disorders. Cochrane Database of Systematic Reviews, Issue 12. Art. No.: CD004025. doi:10.1002/14651858.CD004025.pub3.CrossRefGoogle ScholarPubMed
Mota, NE, Lima, MS, Soares, BG (2002). Amisulpride for schizophrenia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD001357. doi:10.1002/14651858.CD001357.Google ScholarPubMed
Murphy, S, Irving, CB, Adams, CE, Driver, R (2012). Crisis intervention for people with severe mental illnesses. Cochrane Database of Systematic Reviews, Issue 5. Art. No.: CD001087. doi:10.1002/14651858.CD001087.pub4.CrossRefGoogle ScholarPubMed
Newton-Howes, G, Tyrer, P, North, B, Yang, M (2008). The prevalence of personality disorder in schizophrenia and psychotic disorders: systematic review of rates and explanatory modelling. Psychological Medicine 38, 1075–1082.CrossRefGoogle ScholarPubMed
Nieuwenstein, MR, Aleman, A, de Haan, EH (2001). Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous performance test. Journal of Psychiatric Research 35, 119–125.CrossRefGoogle ScholarPubMed
Nussbaum, AM, Stroup, TS (2008). Oral paliperidone for schizophrenia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD006369. doi:10.1002/14651858.CD006369.pub2.CrossRefGoogle ScholarPubMed
O'Driscoll, GA, Callahan, BL (2008). Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993. Brain and Cognition 68, 359–370.CrossRefGoogle ScholarPubMed
Olabi, B, Ellison-Wright, I, McIntosh, AM, Wood, SJ, Bullmore, E, Lawrie, SM (2011). Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biological Psychiatry 70, 88–96.CrossRefGoogle ScholarPubMed
Osborn, DP, Wright, CA, Levy, G, King, MB, Deo, R, Nazareth, I (2008). Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: systematic review and metaanalysis. BMC Psychiatry 8, 84.CrossRefGoogle ScholarPubMed
Oud, MJ, Meyboom-De Jong, B (2009). Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Family Practice 10, 32.CrossRefGoogle ScholarPubMed
Palaniyappan, L, Balain, V, Liddle, PF (2012). The neuroanatomy of psychotic diathesis: a meta-analytic review. Journal of Psychiatric Research 46, 1249–1256.CrossRefGoogle ScholarPubMed
Palmer, BA, Pankratz, VS, Bostwick, JM (2005). The lifetime risk of suicide in schizophrenia: a reexamination. Archives of General Psychiatry 62, 247–253.CrossRefGoogle ScholarPubMed
Patel, S, Mahon, K, Wellington, R, Zhang, J, Chaplin, W, Szeszko, PR (2011). A meta-analysis of diffusion tensor imaging studies of the corpus callosum in schizophrenia. Schizophrenia Research 129, 149–155.CrossRefGoogle ScholarPubMed
Pelletier, M, Achim, AM, Montoya, A, Lal, S, Lepage, M (2005). Cognitive and clinical moderators of recognition memory in schizophrenia: a meta-analysis. Schizophrenia Research 74, 233–252.CrossRefGoogle ScholarPubMed
Pfammatter, M, Junghan, UM, Brenner, HD (2006). Efficacy of psychological therapy in schizophrenia: conclusions from meta-analyses. Schizophrenia Bulletin 32, S64–S80.CrossRefGoogle ScholarPubMed
Pharoah, F, Mari, J, Rathbone, J, Wong, W (2010). Family intervention for schizophrenia. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD000088. doi:10.1002/14651858.CD000088.pub2.CrossRefGoogle ScholarPubMed
Potvin, S, Blanche, P, Stip, E (2009). Substance abuse is associated with increased extrapyramidal symptoms in schizophrenia: a meta-analysis. Schizophrenia Research 113, 181–188.CrossRefGoogle ScholarPubMed
Potvin, S, Marchand, S (2008). Hypoalgesia in schizophrenia is independent of antipsychotic drugs: a systematic quantitative review of experimental studies. Pain 138, 70–78.CrossRefGoogle ScholarPubMed
Potvin, S, Sepehry, AA, Stip, E (2006). A meta-analysis of negative symptoms in dual diagnosis schizophrenia. Psychological Medicine 36, 431–440.CrossRefGoogle ScholarPubMed
Preti, A, Cella, M (2010). Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophrenia Research 123, 30–36.Google ScholarPubMed
Ragland, JD, Laird, AR, Ranganath, C, Blumenfeld, RS, Gonzales, SM, Glahn, DC (2009). Prefrontal activation deficits during episodic memory in schizophrenia. American Journal of Psychiatry 166, 863–874.CrossRefGoogle ScholarPubMed
Rajji, TK, Ismail, Z, Mulsant, BH (2009). Age at onset and cognition in schizophrenia: meta-analysis. British Journal of Psychiatry 195, 286–293.CrossRefGoogle ScholarPubMed
Rattehalli, RD, Jayaram, MB, Smith, M (2010). Risperidone versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD006918. doi:10.1002/14651858.CD006918.pub2.CrossRefGoogle ScholarPubMed
Read, J, Haslam, N, Sayce, L, Davies, E (2006). Prejudice and schizophrenia: a review of the ‘mental illness is an illness like any other’ approach. Acta Psychiatrica Scandinavica 114, 303–318.CrossRefGoogle ScholarPubMed
Rietkerk, T, Boks, MP, Sommer, IE, Liddle, PF, Ophoff, RA, Kahn, RS, Boks, MPM (2008). The genetics of symptom dimensions of schizophrenia: review and meta-analysis. Schizophrenia Research 102, 197–205.CrossRefGoogle ScholarPubMed
Roder, V, Mueller, DR, Schmidt, SJ (2011). Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update. Schizophrenia Bulletin 37, S71–S79.CrossRefGoogle ScholarPubMed
Rosenthal, JA (1996). Qualitative descriptors of strength of association and effect size. Journal of Social Service Research 21, 37–58.CrossRefGoogle Scholar
Rubio, JM, Sanjuán, J, Flórez-Salamanca, L, Cuesta, MJ (2012). Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophrenia Research 138, 248–254.CrossRefGoogle ScholarPubMed
Saha, S, Chant, D, McGrath, J (2007). A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Archives of General Psychiatry 64, 1123–1131.CrossRefGoogle ScholarPubMed
Saha, S, Chant, D, Welham, J, McGrath, J (2005). A systematic review of the prevalence of schizophrenia. PLoS Medicine 2, e141.CrossRefGoogle ScholarPubMed
Sarin, F, Wallin, L, Widerlov, B (2011). Cognitive behavior therapy for schizophrenia: a meta-analytical review of randomized controlled trials. Nordic Journal of Psychiatry 65, 162–174.CrossRefGoogle ScholarPubMed
Savla, GN, Vella, L, Armstrong, CC, Penn, DL, Twamley, EW (2012). Deficits in domains of social cognition in schizophrenia: a meta-analysis of the empirical evidence. Schizophrenia Bulletin. Published online 4 September 2012 . doi:10.1093/schbul/sbs1080.Google ScholarPubMed
Schmidt, SJ, Mueller, DR, Roder, V (2011). Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. Schizophrenia Bulletin 37, S41–S54.CrossRefGoogle ScholarPubMed
Schroeter, ML, Abdul-Khaliq, H, Krebs, M, Diefenbacher, A, Blasig, IE (2009). Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia – original research and meta-analysis. Psychiatry Research 167, 66–72.CrossRefGoogle ScholarPubMed
Schultz, PW, Searleman, A (2002). Rigidity of thought and behavior: 100 years of research. Genetic, Social, and General Psychology Monographs 128, 165–207.Google ScholarPubMed
Shepherd, AM, Matheson, SL, Laurens, KR, Carr, VJ, Green, MJ (2012). Systematic meta-analysis of insula volume in schizophrenia. Biological Psychiatry 72, 775–784.CrossRefGoogle ScholarPubMed
Singh, SP, Singh, V (2011). Meta-analysis of the efficacy of adjunctive NMDA receptor modulators in chronic schizophrenia. CNS Drugs 5, 859–885.CrossRefGoogle Scholar
Singh, V, Singh, SP, Chan, K (2010 a). Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia. International Journal of Neuropsychopharmacology 13, 257–271.CrossRefGoogle ScholarPubMed
Singh, S, Singh, V, Kar, N, Chan, K (2010 b). Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. British Journal of Psychiatry 197, 174–179.CrossRefGoogle ScholarPubMed
Sitskoorn, MM, Aleman, A, Ebisch, SJ, Appels, MC, Kahn, RS (2004). Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophrenia Research 71, 285–295.CrossRefGoogle ScholarPubMed
Slotema, CW, Aleman, A, Daskalakis, ZJ, Sommer, IE (2012). Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophrenia Research 142, 40–45.CrossRefGoogle ScholarPubMed
Snitz, BE, Macdonald, AW 3rd, Carter, CS (2006). Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophrenia Bulletin 32, 179–194.CrossRefGoogle ScholarPubMed
Sommer, I, Ramsey, N, Kahn, R, Aleman, A, Bouma, A (2001). Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis. British Journal of Psychiatry 178, 344–351.CrossRefGoogle ScholarPubMed
Sommer, IE, de Witte, L, Begemann, M, Kahn, RS (2012). Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A meta-analysis. Journal of Clinical Psychiatry 73, 414–419.CrossRefGoogle ScholarPubMed
Sprong, M, Schothorst, P, Vos, E, Hox, J, van Engeland, H (2007). Theory of mind in schizophrenia: meta-analysis. British Journal of Psychiatry 191, 5–13.CrossRefGoogle ScholarPubMed
Stefanopoulou, E, Manoharan, A, Landau, S, Geddes, JR, Goodwin, G, Frangou, S (2009). Cognitive functioning in patients with affective disorders and schizophrenia: a meta-analysis. International Review of Psychiatry 21, 336–356.CrossRefGoogle ScholarPubMed
Su, L, Cai, Y, Wang, L, Shi, S (2012). Various effects of antipsychotics on P50 sensory gating in Chinese schizophrenia patients: a meta-analysis. Psychiatria Danubina 24, 44–50.Google ScholarPubMed
Sullivan, PF, Kendler, KS, Neale, MC (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Archives of General Psychiatry 60, 1187–1192.Google ScholarPubMed
Szoke, A, Schurhoff, F, Mathieu, F, Meary, A, Ionescu, S, Leboyer, M (2005). Tests of executive functions in first-degree relatives of schizophrenic patients: a meta-analysis. Psychological Medicine 35, 771–782.CrossRefGoogle ScholarPubMed
Tandon, R, Keshavan, MS, Nasrallah, HA (2008 a). Schizophrenia, part 1 – Just the Facts. What we know in 2008: an overview. Schizophrenia Research 100, 4–19.CrossRefGoogle Scholar
Tandon, R, Keshavan, MS, Nasrallah, HA (2008 b). Schizophrenia, part 2 – Just the Facts. What we know in 2008. Epidemiology and etiology. Schizophrenia Research 102, 1–18.CrossRefGoogle Scholar
Tandon, R, Nasrallah, HA, Keshavan, MS (2009). Schizophrenia, part 4 – Just the Facts. Clinical features and conceptualization. Schizophrenia Research 110, 1–23.CrossRefGoogle Scholar
Tandon, R, Nasrallah, HA, Keshavan, MS (2010). Schizophrenia, ‘Just the Facts’: 5. Treatment and prevention. Past, present, and future. Schizophrenia Research 122, 1–23.CrossRefGoogle ScholarPubMed
Tarbox, SI, Pogue-Geile, MF (2008). Development of social functioning in preschizophrenia children and adolescents: a systematic review. Psychological Bulletin 134, 561–583.CrossRefGoogle ScholarPubMed
Taylor, SF, Kang, J, Brege, IS, Tso, IF, Hosanagar, A, Johnson, TD (2012). Meta-analysis of functional neuroimaging studies of emotion perception and experience in schizophrenia. Biological Psychiatry 71, 136–145.CrossRefGoogle ScholarPubMed
Tharyan, P, Adams, CE (2005). Electroconvulsive therapy for schizophrenia. Cochrane Database of Systematic Reviews, Issue 2. Art. No.: CD000076. doi:10.1002/14651858.CD000076.pub2.CrossRefGoogle ScholarPubMed
Torrey, EF, Bartko, JJ, Yolken, RH (2012). Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophrenia Bulletin 38, 642–647.CrossRefGoogle ScholarPubMed
Trandafir, A, Meary, A, Schurhoff, F, Leboyer, M, Szoke, A (2006). Memory tests in first-degree adult relatives of schizophrenic patients: a meta-analysis. Schizophrenia Research 81, 217–226.CrossRefGoogle ScholarPubMed
Trzesniak, C, de Oliveira, IR, Kempton, MJ, Galvão-de Almeida, A, Chagas, MHN, Ferrari, MCF, Filho, AS, Zuardi, AW, Prado, DA, Busatto, GF, McGuire, PK, Hallak, JEC, Crippa, JAS (2011 a). Are cavum septum pellucidum abnormalities more common in schizophrenia spectrum disorders? A systematic review and meta-analysis. Schizophrenia Research 125, 1–12.CrossRefGoogle ScholarPubMed
Trzesniak, C, Kempton, MJ, Busatto, GF, de Oliveira, IR, Galvao-de Almeida, A, Kambeitz, J, Ferrari, MCF, Santos, A, Chagas, MHN, Zuardi, AW, Hallak, JEC, McGuire, PK, Crippa, JAS (2011 b). Adhesio interthalamica alterations in schizophrenia spectrum disorders: a systematic review and meta-analysis. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35, 877–886.Google ScholarPubMed
Umbricht, D, Krljes, S (2005). Mismatch negativity in schizophrenia: a meta-analysis. Schizophrenia Research 76, 1–23.CrossRefGoogle ScholarPubMed
van der Kemp, WJM, Klomp, DWJ, Kahn, RS, Luijten, PR, Hulshoff Pol, HE (2012). A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Research 141, 153–161.CrossRefGoogle ScholarPubMed
Van Snellenberg, JX, Torres, IJ, Thornton, AE (2006). Functional neuroimaging of working memory in schizophrenia: task performance as a moderating variable. Neuropsychology 20, 497–510.CrossRefGoogle ScholarPubMed
Vassos, E, Pedersen, CB, Murray, RM, Collier, DA, Lewis, CM (2012). Meta-analysis of the association of urbanicity with schizophrenia. Schizophrenia Bulletin 38, 1118–1123.CrossRefGoogle ScholarPubMed
Ventura, J, Thames, AD, Wood, RC, Guzik, LH, Hellman, GS (2010). Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits. Schizophrenia Research 121, 1–14.CrossRefGoogle ScholarPubMed
Ventura, J, Wood, RC, Hellemann, GS (2013). Symptom domains and neurocognitive functioning can help differentiate social cognitive processes in schizophrenia: a meta-analysis. Schizophrenia Bulletin 39, 102–111.CrossRefGoogle ScholarPubMed
Wang, K, Cheung, EFC, Gong, QY, Chan, RCK (2011). Semantic processing disturbance in patients with schizophrenia: a meta-analysis of the N400 component. PLoS ONE 6, e25435.CrossRefGoogle ScholarPubMed
Wang, Y, Cui, J, Chan, RCK, Deng, Y, Shi, H, Hong, X, Li, Z, Yu, X, Gong, Q-Y, Shum, D (2009). Meta-analysis of prospective memory in schizophrenia: nature, extent, and correlates. Schizophrenia Research 114, 64–70.CrossRefGoogle ScholarPubMed
Waters, F, Woodward, T, Allen, P, Aleman, A, Sommer, I (2012). Self-recognition deficits in schizophrenia patients with auditory hallucinations: a meta-analysis of the literature. Schizophrenia Bulletin 38, 741–750.CrossRefGoogle ScholarPubMed
Weinberg, SM, Jenkins, EA, Marazita, ML, Maher, BS (2007). Minor physical anomalies in schizophrenia: a meta-analysis. Schizophrenia Research 89, 72–85.CrossRefGoogle ScholarPubMed
Welham, J, Isohanni, M, Jones, P, McGrath, J (2009). The antecedents of schizophrenia: a review of birth cohort studies. Schizophrenia Bulletin 35, 603–623.CrossRefGoogle ScholarPubMed
Whyte, MC, McIntosh, AM, Johnstone, EC, Lawrie, SM (2005). Declarative memory in unaffected adult relatives of patients with schizophrenia: a systematic review and meta-analysis. Schizophrenia Research 78, 13–26.CrossRefGoogle ScholarPubMed
Woodberry, KA, Giuliano, AJ, Seidman, LJ (2008). Premorbid IQ in schizophrenia: a meta-analytic review. American Journal of Psychiatry 165, 579–587.CrossRefGoogle ScholarPubMed
Woodward, ND, Purdon, SE, Meltzer, HY, Zald, DH (2005). A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. International Journal of Neuropsychopharmacology 8, 457–472.CrossRefGoogle ScholarPubMed
Wright, IC, Rabe-Hesketh, S, Woodruff, PW, David, AS, Murray, RM, Bullmore, ET (2000). Meta-analysis of regional brain volumes in schizophrenia. American Journal of Psychiatry 157, 16–25.CrossRefGoogle ScholarPubMed
Xia, J, Merinder, LB, Belgamwar, MR (2011). Psychoeducation for schizophrenia. [update of Cochrane Database Syst Rev. 2002;(2):CD002831]. Cochrane Database of Systematic Reviews, Issue 6. Art. No.: CD002831. doi:10.1002/14651858.CD002831.pub2.Google Scholar
Xu, T, Chan, RCK, Compton, MT (2011). Minor physical anomalies in patients with schizophrenia, unaffected first-degree relatives, and healthy controls: a meta-analysis. PLoS ONE 6, e24129.Google ScholarPubMed
Yucel, M, Bora, E, Lubman, DI, Solowij, N, Brewer, WJ, Cotton, SM, Conus, P, Takagi, MJ, Fornito, A, Wood, SJ, McGorry, PD, Pantelis, C (2012). The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophrenia Bulletin 38, 316–330.CrossRefGoogle Scholar